A unified evaluation of differential vaccine efficacy
From MaRDI portal
(Redirected from Publication:6047741)
Recommendations
- Leaky vaccines protect highly exposed recipients at a lower rate: implications for vaccine efficacy estimation and sieve analysis
- Sieve analysis using the number of infecting pathogens
- Assessing trends in vaccine efficacy by pathogen genetic distance
- Design and analysis of vaccine studies
- Hypotheses tests of strain-specific vaccine efficacy adjusted for covariate effects
Cites work
- scientific article; zbMATH DE number 3596112 (Why is no real title available?)
- A multiple imputation approach for the evaluation of surrogate markers in the principal stratification causal inference framework
- A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect
- All of Nonparametric Statistics
- Assessing surrogate endpoints in vaccine trials with case-cohort sampling and the Cox model
- Augmented Designs to Assess Immune Response in Vaccine Trials
- Comparing biomarkers as principal surrogate endpoints
- Design and estimation for evaluating principal surrogate markers in vaccine trials
- Evaluating Candidate Principal Surrogate Endpoints
- Mark-specific hazard ratio model with multivariate continuous marks: an application to vaccine efficacy
- Nonparametric causal effects based on marginal structural models
- Sieve analysis using the number of infecting pathogens
- Statistical Methods for Assessing Differential Vaccine Protection Against Human Immunodeficiency Virus Types
- Statistical identifiability and the surrogate endpoint problem, with application to vaccine trials
Cited in
(12)- Testing and Estimation of Time‐Varying Cause‐Specific Hazard Ratios with Covariate Adjustment
- Allowing for two different mechanisms by which lesion free lung lobes occur in pigs after an experimental challenge: Vaccine performance comparisons
- Predicting overall vaccine efficacy in a new setting by re-calibrating baseline covariate and intermediate response endpoint effect modifiers of type-specific vaccine efficacy
- Sieve analysis using the number of infecting pathogens
- Hypotheses tests of strain-specific vaccine efficacy adjusted for covariate effects
- Endpoints in vaccine trials
- Heterogeneity in disease risk induces falling vaccine protection with rising disease incidence
- Causal inference methods for vaccine sieve analysis with effect modification
- Evaluation of American strangles
- Chop-Lump Tests for Vaccine Trials
- COMPARATIVE DYNAMICS OF MONOVALENT AND BIVALENT VACCINATION FOR IMMUNOLOGICALLY UNRELATED PATHOGENS
- Assessing trends in vaccine efficacy by pathogen genetic distance
This page was built for publication: A unified evaluation of differential vaccine efficacy
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6047741)
